Skip to main content
Terug
Watch Compare

Emmaus Life Sciences, Inc.

Datakwaliteit: 100%
EMMA
OTC Manufacturing Chemicals
€ 0,01
€ 0,00 (0,00%)
Marktkapitalisatie: 701.982,0
Prijs
€ 0,01
Marktkapitalisatie
701.982,0
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -11,83% annually over 5 years
Negative free cash flow of -12.000,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 13,39%
Capital efficient — spends only 0,01% of revenue on capex
Interest coverage of 0,03× — tight debt servicing

Groei

Revenue Growth (5Y)
-11,83%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-25,22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-60,16%
Op. Margin1,85%

Veiligheid

Debt / Equity
N/A
Current Ratio0,07
Interest Coverage0,03

Waardering

PE (TTM)
-0,09
Boven sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDA109,18
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,1 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % -60,2 -41,5
Rev Growth 5Y % -11,8 1,8
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

All Fundamental Metrics
Growth
Revenue Growth (1Y) -25,22% Revenue Growth (3Y) -35,13%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -11,83% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 12,45 M Net Income (TTM) -7,49 M
ROE N/A ROA -33,98%
Gross Margin 93,12% Operating Margin 1,85%
Net Margin -60,16% Free Cash Flow (TTM) -12.000,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,07
Interest Coverage 0,03 Asset Turnover 0,56
Working Capital -59,38 M Tangible Book Value -59,49 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,09 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 109,18 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1,71%
Market Cap 701.982,0 Enterprise Value 29,48 M
Per Share
EPS (Diluted TTM) -0,12 Revenue / Share 0,18
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,01% FCF Conversion 0,16%
SBC-Adj. FCF -58.000 Growth Momentum -13,39

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 12,45 M 16,65 M 29,60 M 18,39 M 20,61 M
Net Income -7,49 M -6,45 M -3,73 M -10,63 M -15,95 M
EPS (Diluted) -0,12 -0,10 -0,07 -0,21 —
Gross Profit 11,60 M 15,45 M 28,26 M 15,80 M 17,30 M
Operating Income 231.000,0 -1,89 M 3,54 M -6,59 M -6,13 M
EBITDA — — — — —
R&D Expenses 313.000,0 657.000,0 1,19 M 1,73 M 4,11 M
SG&A Expenses — — — — —
D&A 39.000,0 22.000,0 32.000,0 53.000,0 59.000,0
Interest Expense 7,13 M 5,49 M 7,38 M 5,01 M 3,10 M
Income Tax 9.000,0 29.000,0 -59.000,0 60.000,0 25.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 21,44 M 23,60 M 35,18 M 48,23 M 56,73 M
Total Liabilities 85,04 M 80,08 M 82,94 M 82,32 M 78,18 M
Shareholders' Equity -63,61 M -56,48 M -47,76 M -34,09 M -21,45 M
Total Debt 27,13 M 28,97 M 30,56 M 30,42 M 22,34 M
Cash & Equivalents 2,13 M 1,39 M 2,55 M 2,02 M 2,28 M
Current Assets 7,75 M 6,77 M 11,51 M 6,29 M 9,09 M
Current Liabilities 69,07 M 63,56 M 61,51 M 54,32 M 37,10 M